Speciality: Hematology
Description:
A warm welcome to all the medical professionals for The Conclusion of our "An Eagle's View" session on Iron Deficiency Anemia. We have taken an evidence-based approach to understanding IDA, and this concluding segment will synthesize our findings into actionable clinical takeaways. The key conclusion is that while oral iron remains a valid first-line option, a more patient-centric and proactive approach, heavily informed by recent data, is essential to close the care gap and improve patient outcomes.
The evidence points to a paradigm shift, where intravenous iron is no longer a last resort but a powerful and safe tool for rapid and effective iron repletion. Recent data support its use in specific patient populations, including those with severe anemia, a need for rapid correction, intolerance to oral iron, or co-morbidities like chronic heart failure and inflammatory bowel disease. This is crucial as a significant portion of patients do not achieve adequate iron repletion with oral supplements alone, leading to persistent symptoms and a reduced quality of life.
Therefore, the ultimate conclusion of this session is a call to action: to critically evaluate each patient's needs and consider the most effective and efficient treatment path from the outset. By integrating a deep understanding of the pros and cons of both oral and intravenous iron, medical professionals can empower themselves to make informed decisions that will directly and positively impact patient well-being. Continue to follow Hidoc for more such indispensable sessions that keep you at the forefront of medical advancements.
See More Webinars @ Hidoc Webinars
1.
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant
2.
Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.
3.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
4.
EBCC: European Breast Cancer Conference
5.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
1.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
2.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
3.
Pathophysiology of Tumor Cell Extracellular Matrix Remodeling
4.
Innovative Advances in Oncology for Specialists
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
Importance of Cancer Screening and Early Detection
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation